Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Aging
|
January 13, 2017
Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in <i>Saccharomyces cerevisiae</i>
Gregory Tombline, Jonathan I Millen, Bogdan Polevoda, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 13, 2010
A high-throughput screen for chemical inhibitors of exocytic transport in yeast
Lisha Zhang, N Miranda Nebane, Krister Wennerberg, et al.
Science Immunology
|
October 31, 2020
Persistent STAT5 activation reprograms the epigenetic landscape in CD4<sup>+</sup> T cells to drive polyfunctionality and antitumor immunity
Zhi-Chun Ding, Huidong Shi, Nada S Aboelella, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
Mohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
Cancers
|
September 27, 2025
Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models
Daniela D De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity
Gary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Cancers
|
February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
Heather N Tinsley, Bini Mathew, Xi Chen, et al.
Molecular Cancer Therapeutics
|
June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
Nan Li, Yaguang Xi, Heather N Tinsley, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Aging
|
January 13, 2017
Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in <i>Saccharomyces cerevisiae</i>
Gregory Tombline, Jonathan I Millen, Bogdan Polevoda, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 13, 2010
A high-throughput screen for chemical inhibitors of exocytic transport in yeast
Lisha Zhang, N Miranda Nebane, Krister Wennerberg, et al.
Science Immunology
|
October 31, 2020
Persistent STAT5 activation reprograms the epigenetic landscape in CD4<sup>+</sup> T cells to drive polyfunctionality and antitumor immunity
Zhi-Chun Ding, Huidong Shi, Nada S Aboelella, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
Mohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
Cancers
|
September 27, 2025
Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models
Daniela D De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity
Gary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Cancers
|
February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
Heather N Tinsley, Bini Mathew, Xi Chen, et al.
Molecular Cancer Therapeutics
|
June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
Nan Li, Yaguang Xi, Heather N Tinsley, et al.
Page
of 12